BREVI-T BIO

Brevi-T Bio, a joint venture between InterOme, a digital health enterprise, and Avrok Biosciences is tackling some of the world’s biggest public health challenges, including infectious diseases, substance abuse, and environmental contaminants through improved practices, plans, and policies. Brevi-T’s mission is to make the world a healthier place, by creating the means to detect, assess, and manage public health risk factors to prevent the spread of epidemics. Brevi-T’s goal is to use actionable data for the best possible individual and public health outcomes.